From laboratory to clinic: Autoantibodies in pediatric rheumatic diseases;Desde el laboratorio a la clínica: Autoanticuerpos en las enfermedades reumáticas en pediatría

Anales de Pediatria Continuada

Volumn 3, Issue 2, 2005, Pages 94-98

  De Inocencio, Jaime ^a   Merino, Rosa ^b  

^a Instituto Madrileno de la Salud   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65249096600     PISSN: 16962818     EISSN: 16964608     Source Type: Journal    
DOI: 10.1016/S1696-2818(05)73266-2     Document Type: Article

References (24)

1. Newkirk MM. Rheumatoid factors: what do they tell us? J Rheumatol. 2002; 29:2034-40.
2. Kasapcopur O, Ozbakir F, Arisoy N, Ingol H, Yazici H, Ozdogan H. Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children. Turk J Pediatr. 1999;41:67-71.
3. Eichenfield AH, Athreya BH, Doughty RA, Cebul RD. Utility of rheumatoid factor in the diagnosis of juvenile rheumatoid arthritis. Pediatrics. 1986;78: 480-4.
4. Shmerling RH, Delbanco TL. How useful is the rheumatoid factor? An analysis of sensitivity, specificity and predictive values. Arch Intern Med. 1992;152:2417-20.
5. López-Longo FJ, Rodríguez Mahou M, Grau R, Carreño L. Autoanticuerpos en las enfermedades reumáticas. Clasificación y técnicas de detección. Rev Esp Reumatol. 1996;23:343-9.
6. •• Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med. 2000;124:71-81.
7. Modesto C. Anticuerpos antinucleares y artritis reumatoide crónica juvenil. An Esp Pediatr. 1996;44:305-9.
8. Klein-Gitelman M, Reiff A, Silverman ED. Systemic lupus erythematosus in childhood. Rheum Dis Clin North Am. 2002;28:561-77.
9. Tan EM, Feltkamp TEW, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 1997;40:1601-11.
10. Malleson PN, Sailer M, Mackinnon MJ. Usefulness of antinuclear antibody testing to screen for rheumaic diseases. Arch Dis Child. 1997;77:299-304.
11. Craig WY, Ledue TB, Jonson AM, Ritchie RF The distribution of antinuclear antibody titers in "normal" children and adults. J Rheumatol. 1999;26:914-9.
12. Cabral DA, Petty RE, Fung M, Malleson PN. Persistent antinuclear antibodies in children without identifiable inflammatory rheumatic or autoimmune disease. Pediatrics. 1992;89:441-4.
13. Deane PMG, Liard G, Siegel DM, Baum J. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics. 1995;95:892-5.
14. • Ravelli A, Martini A. Antiphospholipid antibody syndrome in pediatrics patients. Rheum Dis Clin North Am. 1997;23:657-76.
15. Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatrics. 1996;128:319-23.
16. Aguilar Franco C, Lucia Cuesta JF Anticuerpos antifosfolipido en poblacion pediatrica asintomatica. An Esp Pediatr. 2001;54:444-9.
17. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Pitte JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 1999;42:1309-11.
18. • Levy DM, Massicotte MP, Harvey E, Hebert D, Silverman ED. Thromboembolism in paediatric lupus patients. Lupus. 2003;12:741-6.
19. Crowther MA, Ginsberg JS, Julian J, Math M, Denburg J, Hirsh J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349:1133-8.
20. Ozen S. The spectrum of vasculitis in children. Best Pract Res Clin Rheumatol. 2002;16:411-25.
21. Yalgindag A, Sundel R. Vasculitis in childhood. Curr Opin Rheumatol. 2001; 13:422-7.
22. Gomez Centeno A. Anticuerpos antipeptidos citrulinados en la artritis reumatoide. Rev Esp Reumatol. 2004;31:165-8.
23. Avcin T, Cimaz R, Falcini F, Zulian F, Martini G, Simonini G, et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis. 2002;61:608-11.
24. Van Rossum M, Van Soesbergen R, De Kort S, Ten Cate R, Zwinderman AH, De Jong B, et al. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J Rheumatol. 2003;30:825-8.